Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: DEK over expression as an independent biomarker for poor prognosis in colorectal cancer

Figure 3

Kaplan-Meier analysis of 5-year survival rates in 109 patients with or without DEK highly expressed colorectal cancer in relation to serosal invasion (SI), lymph node (LN) metastasis, CEA level, and tumor stage. (A) Colorectal cancer with serosal invasion concomitant with DEK expression had a significantly lower 5-year survival rate than that without DEK expression (P<0.0001). (B) Colorectal cancer with lymph node metastasis and high DEK expression, had a significantly lower 5-year survival rate than colorectal cancer with lymph node metastasis in the absence of DEK expression (P=0.001). (C) Colorectal cancer patients with high CEA levels concomitant with high DEK expression had lower 5-year survival rates than those without DEK expression (P<0.0001). (D) Late-stage colorectal cancers concomitant with high DEK expression had the lowest 5-year survival rate, which was significantly lower than those without high DEK expression (P=0.004). (H, high; L, low).

Back to article page